Curriculum: MS Pharm Sci: Health Outcomes & Pharmacoeconomics

Curriculum: MS Pharm Sci: Health Outcomes & Pharmacoeconomics
04.15.2024
32
05.06.2024
  • This field is for validation purposes and should be left unchanged.

Application Fees Are Waived for Summer 2024

Apply today and we'll waive the $65 application fee

Summer 2024 Information Session

Join program director Dr. Ana Hincapie, UC Online Enrollment Services Advisors, and Student Success Coordinator Holli Whitney as the walk you through all the information you need to know about the Master's in Health Outcomes Program.

curriculum icon Curriculum at a Glance

For the Master of Science in Health Outcomes & Pharmacoeconomics online, the curriculum includes a total of 32 required semester credit hours to satisfy degree requirements. The curriculum is customizable and students can choose their courses. Students will first take the foundation courses for this program. After that students will take a the available core courses and electives for that semester to satisfy the 32 credit requirement.

Have questions? Speak with an Enrollment Advisor today!

Foundation Courses

Students will take these courses in their first semester. These courses will be offered every semester

Course Title / Description Credit
PHDD 8060
Statistical Principles in Clinical Research
Course: PHDD 8060
Credit: 3
The course is designed to teach the statistical principles involved in designing clinical research studies to support new drug development programs. Statistical analysis techniques commonly used will be discussed as well as the newer approaches being considered. Statistical topics addressed in regulatory guidelines will be discussed. Emphasis will be placed on the use of statistical software such as JMP. Hands on exercises using the latest version of JMP will be conducted in various classes.
3
PCEU 7010
Biostatistics & Research Methods
Course: PCEU 7010
Credit: 3
The course begins with basic statistical concepts, introduces essential descriptive and inferential statistical tests, demonstrates some data analysis tools and collection instruments, then discusses common research methodology for pharmaceutical and cosmetic sciences. Students will learn how to use statistics and research designs to evaluate scientific evidence to make individual and population-based decisions. Students will conduct some simple statistical analysis based on given data sets and interpret the results, as well review clinical research literature.
3
PHDD 8080
Pharmaceutical Economics and Management
Course: PHDD 8080
Credit: 3
This course will provide students a background in project management issues in the conduct of global clinical trials, financial aspects of drug development and pharmacoeconomics of approved drug/drug products. The first module will focus on logistic and strategic issues of project management encountered in modern drug development. It includes exposure to principles of project management of complex programs involving: pharmaceutical development, operations, and regulatory affairs. In addition, the corporate challenges involved with portfolio management and optimization will be presented focusing on tools used for optimum decision making. This knowledge base will be applied towards selective case presentations with the goal to identify critical decision points in the process that dramatically impact the successful launch of a new product. The second module will emphasize the business and financial aspects of drug development, including biotechnology and other innovative small pharmaceutical companies that derive their funding primarily from venture capital funding, business strategies, outsourcing and merger and acquisitions. Valuation of the new chemical/molecule as it evolves in the drug development pipeline will be discussed.
3
Back to Top

Fall Core Courses

These core courses will only be offered in the fall semester

Course Title / Description Credit
PCEU 7050
Ethics in Scientific Research- Pharmacy
Course: PCEU 7050
Credit: 1
Students will learn about the various ethical and moral issues that are often encountered in scientific research including ways to identify and analyze them in the practice of research. The course is designed as an option to meet the NIH and NSF requirements for training in RCR (Responsible conduct of research). Topics to be covered include: RCR principles and guidelines, mentorship, collaborative research, conflict of interests, authorship and plagiarism, intellectual property and data handling, research involving human and animal subjects, scientific integrity and misconduct and social responsibility.
1
PADM 7060
Use of Real-World Data in Health Outcomes Research
Course: PADM 7060
Credit: 3
The objective of this graduate course is to prepare students to evaluate outcomes, comparative effectiveness, and health services research using real-world data (RWD) to generate Real World Evidence (RWE). In this course, students will learn about the contents and structure of typical healthcare databases used to perform outcomes, comparative effectiveness, and health services research, discuss the relative advantages and disadvantages of RWD data and identify methodological challenges of using RWD. Additionally, recent the regulatory framework for RWE and RWD will be discussed.
3
Back to Top

Spring Core Course

These core courses will only be offered in the spring semester

Course Title / Description Credit
PHDD 8070
Phase III/IV Clinical Trials and Research
Course: PHDD 8070
Credit: 3
This course will provide a comprehensive background in the design and conduct of large, multicenter Phase III clinical trials of investigational compounds. Emphasis will be placedon the conduct of studies that include patients with varying demographics (age, gender, genetic background and disease state such as renal and hepatic). Issues pertaining to clinical operations, project management, human subjects protections and data safety monitoring will be discussed. An introduction to principles of population pharmacokinetics and pharmacodynamics will be included. The course will include conceptsof post marketing surveillance of approved drugs for drug safety and idiosyncratic reactions, global approaches for pharmacovigilance and compliance with ICH guidelines for recording and dissemination of adverse events. Issues pertainingto pharmacoepidemiology and clinical utilization/effectiveness of the drug will also bediscussed.
3
PCEU 7010
Biostatistics & Research Methods
Course: PCEU 7010
Credit: 3
The course begins with basic statistical concepts, introduces essential descriptive and inferential statistical tests, demonstrates some data analysis tools and collection instruments, then discusses common research methodology for pharmaceutical and cosmetic sciences. Students will learn how to use statistics and research designs to evaluate scientific evidence to make individual and population-based decisions. Students will conduct some simple statistical analysis based on given data sets and interpret the results, as well review clinical research literature.
3
Back to Top

Summer Core Courses

This core course will only be offered in the summer semester

Course Title / Description Credit
PADM 7050
Pharmacoeconomics & Decision Analytical Modeling
Course: PADM 7050
Credit: 3
This course is designed to provide an understanding of the theory and application of economic evaluation methods used in healthcare decision-making. Various methods such as cost-effectiveness analysis, cost-utility analysis, cost-minimization analysis, and cost-benefit analysis will be discussed to evaluate healthcare services, pharmaceuticals, and medical device products. Additionally, techniques to measure costs and outcomes will be discussed in detail along with assigning the monetary value to outcomes. Different types of models such as decision trees and Markov models will be taught. Students will have a chance to conduct independent group projects using a decision-analytic software package by which they will be able to conduct a cost-effectiveness analysis to compare different therapeutic options.
3
Back to Top

Capstone Courses

Students will take these courses in the last semester. These courses will be offered every semester. We recommend taking PHDD8010 as the final course along with PADM7080.

Course Title / Description Credit
PADM7070
Health Outcomes Capstone I
Course: PADM7070
Credit: 2
This is the first of a two-course sequence. The overall objective is for the students to undertake a supervised literature-based scholarship and/or research in Health Outcomes and Pharmacoeconomics that utilizes skills and concepts of didactic coursework in the program. Students in consultation with faculty supervisor will select capstone topic and methods appropriate to students educational and professional goals.
2
PADM7080
Health Outcomes Capstone II
Course: PADM7080
Credit: 3
This is the second of a two-course sequence. The overall objective is for the students to undertake a supervised literature-based scholarship and/or research in Health Outcomes and Pharmacoeconomics that utilizes skills and concepts of didactic coursework in the program. Students in consultation with faculty supervisor will select capstone topic and methods appropriate to students educational and professional goals.
3
PHDD8010
Global Regulatory and Development Strategies of Drugs and Medical Devices
Course: PHDD8010
Credit: 3
This course provides graduate students with an overview on legal and regulatory aspects relevant to drug and medical device development. This includes intellectual properties protection, global legal and regulatory requirements, protection of human subjects and ethics in clinical research and essential elements of management of global projects. Case studies will be included to underline how regulatory strategiesimpact product marketing and life cycle management. Throughout the course, students will integrate knowledge using specific industry examples with the goal to identify critical decision points in the development that impact success of a new drug or medical device on the market.
3
Back to Top

Electives

Students will choose electives based on the educational and career goals in their fall, summer, and capstone semesters. Please work with your student success coordinator to determine when these courses will be available.

Course Title / Description Credit
HCA 7031
Health Policy 1: Health Policy & Regulation
Course: HCA 7031
Credit: 3
This course is designed to provide students with an overview of how policy is developed and how policies can affect health care in the United States. The course prepares students to understand the steps in the policy creation process and then apply concepts in policy analysis and advocacy. There are five focus areas: need and demand, healthcare finance, ethics & law, preparedness, and policy evaluation. Within the five focus areas, we will examine topics using Bardach’s Eightfold Path: problem definition, agenda setting, implementation, evaluation, and modification. The course will present case studies and readings about real-world problems that health professionals face.
3
HI 7001
The Healthcare and Public Health Landscape
Course: HI 7001
Credit: 3
This course focuses on U.S. healthcare and public health topics such as healthcare delivery, public health services, performance, organization, financing and technology. Key emerging global health topics are taught. The course introduces key public policy impacting health and healthcare,such as policy advocating for patient-centered care, efficiency, quality and safety. The course introduces the role of health information technology and electronic health information sharing. This course also introduces and compares key healthcare quality initiatives.
3
HCA 7001
Health Systems Management 1: Organization & Delivery
Course: HCA 7001
Credit: 3
The course is intended to provide the student with a systems perspective of U.S. health and health care structure and function. As the MHA Program’s introductory course, it provides a basis for all subsequent courses including leadership, systems analysis, finance and economics, quality improvement, policy and law, and others. Topics include an overview of the social, political, economic and structural dynamics which shape health care in the United States as well as current and likely future imperatives health care managers will face. Evaluation is competency-based; students will be expected to demonstrate proficiency at seeking and applying evidence to managerial decision-making, the effective communication of ideas, and a number of different types of analyses relevant to cases and issues affecting U.S. healthcare today.
3
PHDD 8050
Phase I/II Clinical Trials Research and Design
Course: PHDD 8050
Credit: 3
This course will provide an understanding on the early clinical drug development activities for newchemical entity that has received IND approval. Concepts of early clinical pharmacology studies, typically conducted in a Phase I setting such as single and multiple dose pharmacokinetics, dose escalation studies to determine the safety and tolerability of drug, mass balance and drug metabolism studies and bioavailability studies will be taught. Emphasis will then be placed on Phase II trials as proof-of-principle, and on the dose-ranging requirements for Phase II. Trial designs including cross-over and parallel group will be discussed. The importance of Phase I/II trials for making dose selections for Phase III will be explored, as will the use of Phase II trials as a go/no-go decision point. The importance of exposure-response (PK/PD) information in guiding the go/no-go decision will also be discussed. The use of biomarkers and pharmacogenomic information in decision making will be addressed. Activities which run in parallel to PhaseI/II trials, including formulation development and clinical supplies and toxicology studies will be discussed.
3
HI7010
Health Informatics, Information Systems and Technology
Course: HI7010
Credit: 3
This course introduces the discipline of health informatics and covers emerging trends. Various information systems, technologies and applications utilized in the context of health and healthcare are introduced. Their characteristics, strengths, challenges, purpose and impact are taught. Impact on patients, populations and healthcare providers is emphasized. Factors influencing adoption and use of various clinical and health information systems and technologies are taught. Key information technologies and systems such as electronic health records, health information exchanges, personal health records, public health information systems and mobile health technologies are introduced in this course. Topics such as telemedicine, interoperability and technical concepts are taught, and evaluation framework is introduced.
3
BANA 7015
Advanced Health Care Data Analytics, Business Intelligence, and Reporting
Course: BANA 7015
Credit: 3
This course teaches the use of healthcare data to make decisions and transform healthcare delivery and the health of individuals and populations. The course concentrates on big and small data, and structured and unstructured data. Tools, applications and approaches for health data analytics are taught. This course covers topics such as statistical approaches; data, web and textmining; data visualization, simulation, modeling and forecasting. Key regulatory health and healthcare reporting requirements are taught.
3
HI 7072
Leveraging Analytics and Business Intelligence Tools for Healthcare
Course: HI 7072
Credit: 3
This course will introduce students to a variety of cutting edge analytics and business intelligence tools applicable to health or healthcare data. Both structured and unstructured data will be introduced in this course. The coursewill also address topics related to data governance and data quality and various other topics relevant to health data management. This course is predominately hands-on and students willcomplete a project to demonstrate skills acquired.Students will learn how other industries have applied similar or the same tools.
3
HI 7030
Health Information Legislation, Privacy and Security
Course: HI 7030
Credit: 3
This course introduces legislation relevant to electronic health information privacy and information security. Topics such as electronic health information privacy and security safeguards, risk assessment methodology and contingency planning are taught. Students learn how to mitigate risk to business continuity and plan for disaster recovery.
3
Back to Top